SS Innovations International Inc. Common Stock (SSII) - Net Assets

Latest as of December 2025: $38.22 Million USD

Based on the latest financial reports, SS Innovations International Inc. Common Stock (SSII) has net assets worth $38.22 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($74.23 Million) and total liabilities ($36.01 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read how much debt does SS Innovations International Inc. Common carry for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric Value
Current Net Assets $38.22 Million
% of Total Assets 51.49%
Annual Growth Rate N/A
5-Year Change 26942.62%
10-Year Change N/A
Growth Volatility 858.16

SS Innovations International Inc. Common Stock - Net Assets Trend (2016–2025)

This chart illustrates how SS Innovations International Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. Also explore SSII asset base for the complete picture of this company's asset base.

Annual Net Assets for SS Innovations International Inc. Common Stock (2016–2025)

The table below shows the annual net assets of SS Innovations International Inc. Common Stock from 2016 to 2025. For live valuation and market cap data, see SSII company net worth.

Year Net Assets Change
2025-12-31 $38.22 Million +184.00%
2024-12-31 $13.46 Million -5.88%
2023-12-31 $14.30 Million +633.80%
2022-12-31 $-2.68 Million -1995.29%
2021-12-31 $141.33K +116.26%
2020-12-31 $-869.05K +18.27%
2019-12-31 $-1.06 Million -249.35%
2018-12-31 $-304.35K -401.06%
2017-12-31 $101.09K +128.47%
2016-12-31 $-355.06K --

Equity Component Analysis

This analysis shows how different components contribute to SS Innovations International Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 5530488600.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock $19.42K 0.05%
Other Comprehensive Income $-1.12 Million -2.94%
Other Components $95.11 Million 248.86%
Total Equity $38.22 Million 100.00%

SS Innovations International Inc. Common Stock Competitors by Market Cap

The table below lists competitors of SS Innovations International Inc. Common Stock ranked by their market capitalization.

Company Market Cap
Goldcard High-Tech Co Ltd
SHE:300349
$798.55 Million
ORIENT SECUR.CO.LTD.H YC1
F:OS9
$798.57 Million
WESTLIFE FOODWORLD LIMITED
NSE:WESTLIFE
$798.76 Million
Metro Healthcare Indonesia
JK:CARE
$798.81 Million
G-Shank Enterprise Co Ltd
TW:2476
$798.50 Million
Kvutzat Acro Ltd.
TA:ACRO
$798.22 Million
Relmada Therapeutics Inc
NASDAQ:RLMD
$798.21 Million
Huawen Media Investment Corp
SHE:000793
$797.87 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in SS Innovations International Inc. Common Stock's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 13,457,103 to 38,218,251, a change of 24,761,148 (184.0%).
  • Net loss of 12,127,387 reduced equity.
  • Other comprehensive income decreased equity by 1,273,035.
  • Other factors increased equity by 38,161,570.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-12.13 Million -31.73%
Other Comprehensive Income $-1.27 Million -3.33%
Other Changes $38.16 Million +99.85%
Total Change $- 184.00%

Book Value vs Market Value Analysis

This analysis compares SS Innovations International Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 20.74x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-12-31 $-0.19 $3.99 x
2017-12-31 $0.05 $3.99 x
2018-12-31 $-0.15 $3.99 x
2019-12-31 $-0.49 $3.99 x
2020-12-31 $-0.37 $3.99 x
2021-12-31 $0.05 $3.99 x
2022-12-31 $-0.67 $3.99 x
2023-12-31 $0.11 $3.99 x
2024-12-31 $0.07 $3.99 x
2025-12-31 $0.19 $3.99 x

Capital Efficiency Dashboard

This dashboard shows how efficiently SS Innovations International Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -31.73%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -28.59%
  • • Asset Turnover: 0.57x
  • • Equity Multiplier: 1.94x
  • Recent ROE (-31.73%) is above the historical average (-239.73%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 0.00% 0.00% 0.00x 0.00x $-449.48K
2017 -1026.50% 0.00% 0.00x 5.04x $-1.05 Million
2018 0.00% 0.00% 0.00x 0.00x $-929.89K
2019 0.00% 0.00% 0.00x 0.00x $-3.28 Million
2020 0.00% 0.00% 0.00x 0.00x $-1.04 Million
2021 -1050.28% 0.00% 0.00x 3.03x $-1.50 Million
2022 0.00% -384.11% 0.21x 0.00x $-5.33 Million
2023 -146.47% -356.17% 0.23x 1.78x $-22.37 Million
2024 -142.31% -92.74% 0.49x 3.15x $-20.50 Million
2025 -31.73% -28.59% 0.57x 1.94x $-15.95 Million

Industry Comparison

This section compares SS Innovations International Inc. Common Stock's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $2,555,245,291
  • Average return on equity (ROE) among peers: -57.95%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
SS Innovations International Inc. Common Stock (SSII) $38.22 Million 0.00% 0.94x $798.52 Million
Abbott Laboratories (ABT) $24.08 Billion 18.37% 0.83x $155.56 Billion
Adagio Medical Holdings, Inc Common Stock (ADGM) $-95.88 Million 0.00% 0.00x $21.60 Million
Aethlon Medical Inc (AEMD) $9.29 Million -84.45% 0.15x $2.79 Million
Acutus Medical Inc (AFIB) $105.73 Million -116.68% 0.61x $903.35K
Adapthealth Corp (AHCO) $1.47 Billion -46.29% 2.07x $1.39 Billion
20/20 Biolabs, Inc. Common Stock (AIDX) $3.39 Million -59.65% 0.38x $15.99 Million
Allurion Technologies, Inc. (ALUR) $-70.49 Million 0.00% 0.00x $8.10 Million
Autonomix Medical, Inc. Common Stock (AMIX) $644.00K -309.01% 0.34x $4.22 Million
Artivion Inc (AORT) $30.20 Million 15.56% 0.78x $1.73 Billion
Apyx Medical Inc (APYX) $22.89 Million 2.69% 0.23x $125.55 Million

About SS Innovations International Inc. Common Stock

NASDAQ:SSII USA Medical Devices
Market Cap
$798.52 Million
Market Cap Rank
#10168 Global
#2581 in USA
Share Price
$3.99
Change (1 day)
-0.75%
52-Week Range
$3.24 - $10.75
All Time High
$11.35
About

SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The comp… Read more